Brief Title
Platform for Clinical Trials in Nutrition and Health
Protocol ID
NCT04067921
Lead Sponsor
IMDEA Food
Brief Summary
Despite the known link between dietary patterns and disease, it has been observed that
the specific response of each individual to dietary components highly varied, and this
may limit the impact of the nutritional interventions to improve public health. These
observations provided the basis to the development of the Nutritional Genomics at the
beginning of the 90s, which main goal was to study the interaction between dietary
factors and the genome that modulate phenotypic expression. From this idea, in the recent
years, Precision Nutrition has been emerged as a therapeutic approach that takes into
account all individual's characteristics to develop targeted nutritional advices. The
main goal of Precision Nutrition is to maintain or improve health by using genetics,
phenotypic, clinical, dietary and other information to provide more precise and more
efficacious personalized healthy eating advice and to motivate appropriate dietary
changes. However, all the genotype-dependent advice must be based on scientific evidence.
Most of the available evidence in support of personalized nutrition has come from
observational studies with risk factors as outcomes, and it was needed randomized
controlled trials using clinical endpoints to ratify these results.
The main objective of the Platform for Clinical Trials in Nutrition and Health (GENYAL)
is to contribute to Precision Nutrition Research by the construction, for the first time,
of a human gene and phenotype database to be used in: 1) The evaluation of the efficacy
of different foods, functional foods and bioactive compounds capsules on general
population and by genotypes and 2) The performance of nutritional genetics and
nutrigenomics studies. For that purposes, GENYAL has a permanent recruitment of
volunteers, which are phenotypically and genotypically characterized, and give consent to
be contacted to perform clinical trials and nutritional intervention studies. Therefore,
GENYAL may help to increase the existing knowledge for moving along to Nutritional
Genomics research to its practical application in Precision Nutrition; contributing in
the improvement in health and disease prevention through dietary recommendations based on
the genome.
Study Period
-
Enrollment Count
1,963 participants
Eligibility Criteria
Inclusion Criteria:
- Free-living adults aged from 18 to 70 years that give written informed consent to be
contacted to perform clinical trials and nutritional intervention studies.
Exclusion Criteria:
- Suffering from any serious illness (kidney or liver diseases or other condition that
affects lifestyle or diet).
- Presenting dementia or impaired cognitive function
- Being pregnant or breastfeeding.
Filters
Healthy Volunteers
UNKNOWN
ADULT
OLDER_ADULT